HKSE:01763 (China)
Â
Ordinary Shares - Class H
HK$
10.86
(-2.69%)
May 24
Current and historical daily PE Ratio for China Isotope & Radiation Corp (
HKSE:01763
) from 2018 to May 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. China Isotope & Radiation stock (HKSE:01763) PE ratio as of May 24 2024 is 8.56.
More Details
China Isotope & Radiation Corp (HKSE:01763) PE Ratio (TTM) Chart
China Isotope & Radiation Corp (HKSE:01763) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1213
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| China Isotope & Radiation PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-24 | 8.6 | 2024-03-15 | 9.1 |
| 2024-05-23 | 8.8 | 2024-03-14 | 9.2 |
| 2024-05-22 | 8.9 | 2024-03-13 | 9.4 |
| 2024-05-21 | 8.7 | 2024-03-12 | 9.4 |
| 2024-05-20 | 9.1 | 2024-03-11 | 9.3 |
| 2024-05-17 | 8.8 | 2024-03-08 | 9.1 |
| 2024-05-16 | 8.8 | 2024-03-07 | 8.9 |
| 2024-05-14 | 8.8 | 2024-03-06 | 9.1 |
| 2024-05-13 | 8.9 | 2024-03-05 | 8.9 |
| 2024-05-10 | 8.7 | 2024-03-04 | 9.3 |
| 2024-05-09 | 8.7 | 2024-03-01 | 9.4 |
| 2024-05-08 | 8.3 | 2024-02-29 | 9.4 |
| 2024-05-07 | 8.4 | 2024-02-28 | 9.3 |
| 2024-05-06 | 8.6 | 2024-02-27 | 9.5 |
| 2024-05-03 | 8.6 | 2024-02-26 | 9.4 |
| 2024-05-02 | 8.7 | 2024-02-23 | 9.5 |
| 2024-04-30 | 8.3 | 2024-02-22 | 9.4 |
| 2024-04-29 | 8.5 | 2024-02-21 | 9.3 |
| 2024-04-26 | 8.5 | 2024-02-20 | 9.1 |
| 2024-04-25 | 8.1 | 2024-02-19 | 9.2 |
| 2024-04-24 | 8.2 | 2024-02-16 | 9.1 |
| 2024-04-23 | 8.1 | 2024-02-15 | 8.8 |
| 2024-04-22 | 7.8 | 2024-02-14 | 8.8 |
| 2024-04-19 | 7.3 | 2024-02-09 | 8.8 |
| 2024-04-18 | 7.4 | 2024-02-08 | 9.2 |
| 2024-04-17 | 7.4 | 2024-02-07 | 9.1 |
| 2024-04-16 | 7.4 | 2024-02-06 | 9.1 |
| 2024-04-15 | 7.7 | 2024-02-05 | 8.8 |
| 2024-04-12 | 7.8 | 2024-02-02 | 9.0 |
| 2024-04-11 | 8.1 | 2024-02-01 | 9.2 |
| 2024-04-10 | 8.1 | 2024-01-31 | 9.1 |
| 2024-04-09 | 8.2 | 2024-01-30 | 9.2 |
| 2024-04-08 | 8.2 | 2024-01-29 | 9.4 |
| 2024-04-05 | 8.2 | 2024-01-26 | 9.5 |
| 2024-04-03 | 8.0 | 2024-01-25 | 9.6 |
| 2024-04-02 | 8.1 | 2024-01-24 | 9.1 |
| 2024-03-28 | 8.0 | 2024-01-23 | 9.1 |
| 2024-03-27 | 8.8 | 2024-01-22 | 9.0 |
| 2024-03-26 | 9.0 | 2024-01-19 | 9.3 |
| 2024-03-25 | 9.2 | 2024-01-18 | 9.5 |
| 2024-03-22 | 9.2 | 2024-01-17 | 9.6 |
| 2024-03-21 | 9.4 | 2024-01-16 | 9.7 |
| 2024-03-20 | 9.3 | 2024-01-15 | 9.9 |
| 2024-03-19 | 9.2 | 2024-01-12 | 9.8 |
| 2024-03-18 | 9.3 | 2024-01-11 | 9.9 |
China Isotope & Radiation Corp (HKSE:01763) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
China Isotope & Radiation Corp
ISIN : CNE1000031F4
Share Class Description:
HKSE:01763: Ordinary Shares - Class HCompare
Compare
Traded in other countries / regions
01763.Hong Kong IPO Date
2018-07-06Description
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers